Vanguard Group Inc Bluejay Diagnostics, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.83 - $132.53 $13,196 - $2.11 Million
15,899 New
15,899 $12,000
Q1 2022

May 13, 2022
SELL
$0.86 - $2.92 $27,666 - $93,936
-32,170 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$2.33 - $5.32 $74,956 - $171,144
32,170 New
32,170 $82,000

About Bluejay Diagnostics, Inc.

BJDX Quotes by TradingView
  • Ticker BJDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,152,300
  • Market Cap $71.3M
  • Description
  • Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoass...
More about BJDX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email